Since there is no abstract available, we provide the first paragraph
Human Genetic and Structural Genomic Variation: Would Genome-Wide Association Studies Be the Solution for Cancer Complexity?
Rapid technological advances with cheaper high throughput DNA sequencing techniques now allow genomewide association studies (GWAS) to assess novel gene variants associated with complex diseases, including cancer. [1, 2] These genetic variants could potentially be used in the clinic for personalized preventive and therapeutic interventions, as a means of personalized medicine. [3]